Drug manufacturer must pay $125M in health care fraud case

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

BOSTON (AP) — A federal judge in Boston has ordered the former pharmaceutical company Warner Chilcott to pay $125 million to resolve criminal and civil claims in a health care fraud case.

U.S. District Judge F. Dennis Saylor IV imposed the sentence Friday, six months after the company pleaded guilty in connection with a scheme to illegally promote its drugs.

Prosecutors alleged that from 2009 to 2013, employees provided payments, meals and other remuneration to doctors to induce them to prescribe Warner Chilcott's drugs.

The company was bought in 2013 by Dublin, Ireland-based Actavis PLC, which changed its name to Allergan Inc. after buying that company.

An Allergan spokesman declined to comment.

Warner Chilcott's former president, W. Carl Reichel, is charged with conspiring to pay kickbacks to doctors. He denies the allegations.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business & Tech stories

Related topics

Business & Tech
The Associated Press


    Catch up on the top news and features from KSL.com, sent weekly.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast